- Home
- UAMY vs PMN Comparison
UAMY vs PMN Comparison
Compare UAMY & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- PMN
- Stock Information
- Founded
- UAMY 1968
- PMN 2004
- Country
- UAMY United States
- PMN Canada
- Employees
- UAMY N/A
- PMN N/A
- Industry
- UAMY Metal Fabrications
- PMN Pharmaceuticals and Biotechnology
- Sector
- UAMY Industrials
- PMN Health Care
- Exchange
- UAMY Nasdaq
- PMN Nasdaq
- Market Cap
- UAMY 251.9M
- PMN 16.0M
- IPO Year
- UAMY N/A
- PMN N/A
- Fundamental
- Price
- UAMY $2.57
- PMN $0.40
- Analyst Decision
- UAMY Strong Buy
- PMN Strong Buy
- Analyst Count
- UAMY 4
- PMN 2
- Target Price
- UAMY $3.38
- PMN $4.50
- AVG Volume (30 Days)
- UAMY 4.6M
- PMN 63.7K
- Earning Date
- UAMY 08-08-2025
- PMN 08-07-2025
- Dividend Yield
- UAMY N/A
- PMN N/A
- EPS Growth
- UAMY N/A
- PMN N/A
- EPS
- UAMY N/A
- PMN N/A
- Revenue
- UAMY $18,865,900.00
- PMN N/A
- Revenue This Year
- UAMY $270.45
- PMN N/A
- Revenue Next Year
- UAMY $104.06
- PMN N/A
- P/E Ratio
- UAMY N/A
- PMN N/A
- Revenue Growth
- UAMY 97.46
- PMN N/A
- 52 Week Low
- UAMY $0.27
- PMN $0.38
- 52 Week High
- UAMY $3.86
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- UAMY 53.87
- PMN 32.23
- Support Level
- UAMY $2.71
- PMN $0.48
- Resistance Level
- UAMY $2.33
- PMN $0.50
- Average True Range (ATR)
- UAMY 0.23
- PMN 0.03
- MACD
- UAMY 0.00
- PMN -0.01
- Stochastic Oscillator
- UAMY 66.36
- PMN 18.75
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.